samedan logo
 
 
 
spacer
home > pmps > spring 2019 > maintaining security and sterility
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Maintaining Security and Sterility

Many of today’s newer pharmaceutical formulas require more stringent moisture, light, or oxygen protection. Formulas are also becoming more potent, leading to demand for metered dosing in small tube diameters for low (yet powerful) fill volumes. Here, small high-barrier tubes offer attractive user-friendliness and can diminish over-packaging by eliminating the need for secondary packaging like pouches and barrier blisters. They can also provide increased safety through simplicity: the fewer ‘moving parts’ a package has, the lower the likelihood of accidental misuse by end-users.

The Tube Packaging Market

Looking at the larger picture, it is interesting to note that, according to MarketsandMarkets, the worldwide tube packaging market is projected to grow at a compound annual growth rate of 6.9% during the forecast period of 2016 to 2021, approaching US $9.3 billion by 2021 (1).

The tube packaging market is gaining momentum due to factors that include overall growth in the flexible packaging sector and increased demand for small size packs for cosmetic and personal care products. Additional factors driving the market are advancements in tube technologies and, as previously noted, heightened demand for enhanced barrier properties to protect sensitive pharmaceutical products.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Martina Christiansen is Head of Sales and Marketing Pharmaceutical at Hoffmann Neopac, a global provider of high-quality tube packaging for a broad array of industries and applications.
spacer
Martina Christiansen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Kirsten de Bruijn joins Qatar Airways Cargo

An Air Cargo veteran with 13 years of experience in management in the air cargo industry, she shares Qatar Airways belief that the pace of change brought about by recent global events demands value centred leadership around revenue and margin management.
More info >>

White Papers

Case Study: Cmed’s Mobile Data Management Solution

Cmed Clinical Services

The trial presented to Cmed was a randomized, double blinded, placebo and active controlled study to evaluate the cardiac safety of multiple doses of [study drug] in health volunteers. The pharmaceutical company, who were into the second year of development of a potential blockbuster compound for the treatment of chronic myelogenous leukaemia (CML), were requested by the FDA to design a trial to provide information on the cardiac safety of different dose levels of the study drug in healthy adult volunteers. The primary objective of the study was specifically to find the maximum tolerated dose before QTc levels became unsafe. All development of the compound was put on hold until the results of this study were submitted to the FDA and approval granted for the compound to progress into full development.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement